Accurate quantification of basal plasma levels of 3-nitrotyrosine and 3-nitrotyrosinoalbumin by gas chromatography-tandem mass spectrometry
スポンサーリンク
概要
- 論文の詳細を見る
- 2003-01-25
著者
-
Gutzki F‐m
Institut Fur Klinische Pharmakologie Medizinische Hochschule Hannover
-
SCHWEDHELM Edzard
Institute of Experimental and Clinical Pharmacology, University Medical Center Hamburg-Eppendorf
-
GUTZKI Frank-Mathias
Institute of Clinical Pharmacology, Hannover Medical School
-
TSIKAS Dimitrios
Institute of Clinical Pharmacology, Hannover Medical School
-
FROLICH Jurgen
Institute of Clinical Pharmacology, Hannover Medical School
-
STUTZER Friedericke
Institute of Clinical Pharmacology, Hannover Medical School
-
RODE Iris
Institute of Clinical Pharmacology, Hannover Medical School
-
MEHLS Christina
Institute of Clinical Pharmacology, Hannover Medical School
-
Gutzki Frank-mathias
Institut Fur Klinische Pharmakologie Medizinische Hochschule Hannover
-
Froelich J
Institute Of Clinical Pharmacology Hannover Medical School
-
Tsikas D
Institut Fur Klinische Pharmakologie Medizinische Hochschule Hannover
-
Rode Iris
Institute Of Clinical Pharmacology Hannover Medical School
-
Frolich Jurgen
Institute Of Clinical Pharmacology Hannover Medical School
-
Tsikas Dimitrios
Institute For Clinical Pharmacology Hannover Medical School
-
Stutzer Friedericke
Institute Of Clinical Pharmacology Hannover Medical School
-
Mehls Christina
Institute Of Clinical Pharmacology Hannover Medical School
-
Gutzki Frank-mathias
Institute For Clinical Pharmacology Hannover Medical School
-
Schwedhelm Edzard
Institute Of Experimental And Clinical Pharmacology And Toxicology University Medical Center Hamburg
関連論文
- A stable-isotope based technique for the determination of dimethylarginine dimethylaminohydrolase (DDAH) activity in mouse tissue
- High-throughput liquid chromatographic-tandem mass spectrometric determination of arginine and dimethylated arginine derivatives in human and mouse plasma
- Comparison of HPLC method and commercial ELISA assay for asymmetric dimethylarginine (ADMA) determination in human serum
- Determination of N^G,N^G-dimethyl-L-arginine, an endogenous NO synthase inhibitor, by gas chromatography-mass spectrometry
- GC-MS assay for hepatic DDAH activity in diabetic and non-diabetic rats by measuring dimethylamine (DMA) formed from asymmetric dimethylarginine (ADMA) : Evaluation of the importance of S-nitrosothiols as inhibitors of DDAH activity in vitro and in vivo i
- 9- and 10-Nitro-oleic acid do not interfere with the GC-MS quantitative determination of nitrite and nitrate in biological fluids when measured as their pentafluorobenzyl derivatives
- Accurate quantification of dimethylamine (DMA) in human plasma and serum by GC-MS and GC-tandem MS as pentafluorobenzamide derivative in the positive-ion chemical ionization mode
- Accurate quantification of dimethylamine (DMA) in human urine by gas chromatography-mass spectrometry as pentafluorobenzamide derivative : Evaluation of the relationship between DMA and its precursor asymmetric dimethylarginine (ADMA) in health and diseas
- Determination of 3-nitrotyrosine in human urine at the basal state by gas chromatography-tandem mass spectrometry and evaluation of the excretion after oral intake
- Gas chromatography-mass spectrometry of cis-9,10-epoxyoctadecanoic acid (cis-EODA) : II. Quantitative determination of cis-EODA in human plasma
- Divergence in urinary 8-iso-PGF_ (iPF_-III, 15-F_-IsoP) levels from gas chromatography-tandem mass spectrometry quantification after thin-layer chromatography and immunoaffinity column chromatography reveals heterogeneity of 8-iso-PGF_ Pos
- Gas chromatography-mass spectrometry of cis-9, 10-epoxyoctadecanoic acid (cis-EODA) I. Direct evidence for cis-EODA formation from oleic acid oxidation by liver microsomes and isolated hepatocytes
- Accurate quantification of basal plasma levels of 3-nitrotyrosine and 3-nitrotyrosinoalbumin by gas chromatography-tandem mass spectrometry
- Gas chromatographic-tandem mass spectrometric quantification of human plasma and urinary nitrate after its reduction to nitrite and derivatization to the pentafluorobenzyl derivative
- Interference by S-nitroso compounds with the measurement of nitrate in methods requiring reduction of nitrate to nitrite by cadmium
- Measurement of S-nitrosoalbumin by gas chromatography-mass spectrometry : II. Quantitative determination of S-nitrosoalbumin in human plasma using S-[^N]nitrosoalbumin as internal standard
- Measurement of S-nitrosoalbumin by gas chromatography-mass spectrometry : I. Preparation, purification, isolation, characterization and metabolism of S-[^N]nitrosoalbumin in human blood in vitro
- Specific and rapid quantification of 8-iso-prostaglandin F_ in urine of healthy humans and patients with Zellweger syndrome by gas chromatography-tandem mass spectrometry
- Measurement of nitrite and nitrate in plasma, serum and urine of humans by high-performance liquid chromatography, the Griess assay, chemiluminescence and gas chromatography-mass spectrometry : Interferences by biogenic amines and N^G-nitro-L-arginine ana
- Gas chromatographic-tandem mass spectrometric determination of acetylsalicylic acid in human plasma after oral administration of low-dose aspirin and guaimesal
- High-performance liquid chromatographic analysis of nitrite and nitrate in human plasma as S-nitroso-N-acetylcysteine with ultraviolet absorbance detection
- Analysis of cysteine and N-acetylcysteine in human plasma by high-performance liquid chromatography at the basal state and after oral administration of N-acetylcysteine
- GC-MS analysis of S-nitrosothiols after conversion to S-nitroso-N-acetyl cysteine ethyl ester and in-injector nitrosation of ethyl acetate
- GC-MS determination of creatinine in human biological fluids as pentafluorobenzyl derivative in clinical studies and biomonitoring : Inter-laboratory comparison in urine with Jaffe, HPLC and enzymatic assays
- Specific GC-MS/MS stable-isotope dilution methodology for free 9- and 10-nitro-oleic acid in human plasma challenges previous LC-MS/MS reports
- Application of a stable-isotope dilution technique to study the pharmacokinetics of human ^N-labelled S-nitrosoalbumin in the rat : Possible mechanistic and biological implications
- Quantification of N-(3-chloro-2-hydroxypropyl) valine in human haemoglobin as a biomarker of epichlorohydrin exposure by gas chromatography-tandem mass spectrometry with stable-isotope dilution
- HPLC analysis of human erythrocytic glutathione forms using OPA and N-acetyl-cysteine ethyl ester : Evidence for nitrite-induced GSH oxidation to GSSG
- Targeted stable-isotope dilution GC-MS/MS analysis of the endocannabinoid anandamide and other fatty acid ethanol amides in human plasma
- Quantification of arginine and its mono- and dimethylated analogs NMMA, ADMA and SDMA in biological fluids by LC-MS/MS : Is LC superfluous?
- Analysis of nitrite and nitrate in biological fluids by assays based on the Griess reaction : Appraisal of the Griess reaction in the L-arginine/nitric oxide area of research
- Application of gas chromatography-mass spectrometry and gas chromatography-tandem mass spectrometry to assess in vivo synthesis of prostaglandins, thromboxane, leukotrienes, isoprostanes and related compounds in humans
- Determination of dimethylated arginines in human plasma by high-performance liquid chromatography
- Recent methodological advances in the mass spectrometric analysis of free and protein-associated 3-nitrotyrosine in human plasma
- Quantitative analysis of biomarkers, drugs and toxins in biological samples by immunoaffinity chromatography coupled to mass spectrometry or tandem mass spectrometry : A focused review of recent applications
- Analysis of the L-arginine/NO pathway
- Assessment of nitric oxide biosynthesis and peroxynitrite formation within the central nervous system by measuring L-citrulline in the cerebrospinal fluid?
- A proposal for comparing methods of quantitative analysis of endogenous compounds in biological systems by using the relative lower limit of quantification (rLLOQ)
- De novo synthesis of trideuteromethyl esters of amino acids for use in GC-MS and GC-tandem MS exemplified for ADMA in human plasma and urine : Standardization, validation, comparison and proof of evidence for their aptitude as internal standards